Kuehne+Nagel's QuickSTAT opens pharma and healthcare tower in Singapore
Kuehne+Nagel’s subsidiary, QuickSTAT announces the opening of a new control tower and conditioning facility in Singapore to further expand their logistics capabilities to serve customers across Asia Pacific.
QuickSTAT, a subsidiary of Kuehne+Nagel, has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT's pharma and healthcare strategy to further expand their logistics capabilities to serve customers across Asia Pacific.
Singapore is a strategic location for the new QuickSTAT facility, as a leading biomedical science hub in the heart of Asia and its proximity to the rest of the region.
QuickSTAT is an expert in managing global clinical trial logistics for all phases of the product lifecycle from research and drug development through to commercialisation.
The company specialises in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies and vaccines in order to help bring new drugs and medical protocols to market.
The new conditioning facility located at Kuehne+Nagel’s regional centre of excellence - the Singapore Logistics Hub - caters to a full suite of healthcare logistics services for all stages of the pharmaceutical product lifecycle.
Jack Liu, senior vice president, Air Logistics of Kuehne+Nagel Asia Pacific said, “Kuehne+Nagel is delighted to partner with QuickSTAT to provide seamless end-to-end solutions, adding value to our pharma and healthcare customers in Asia Pacific. With the ISO-certified and GXP compliant facility that upholds the best practices for storage, conditioning, transportation, routings and logistics – I am confident that we will consistently deliver product integrity and patient safety.”
It provides superior management of cell and gene therapies, where QuickSTAT’s specialists will ensure proper handling, packaging and storage of the time-and-temperature sensitive products. Additionally, the facility includes a controlled-ambient warehouse and in-transit storage for vaccines, investigational drugs, patient clinical specimens and active pharmaceutical ingredient (API).
“We are committed to providing innovative and customised logistics as well as transportation solutions to meet the ever-challenging demands of the pharma, biotech and life science industry, in all regions of the world. By continuing to expand our global footprint to locations of strategic importance, we are able to provide local and global support for Kuehne+Nagel and QuickSTAT customers,” said Cyril Leger, executive vice president of QuickSTAT.
